TrialLeukemia2024

Identification, risk factors, and clinical course of CNS relapse in DLBCL patients across 19 prospective phase 2 and 3 trials-a LYSA and GLA/ DSHNHL collaboration.

Fabian Frontzek et al.PubMed ↗Publisher ↗

No numbers read from the abstract.